Back to Search
DR. MOHAMMAD D AZIZI MD
MD
Anesthesiology Physician
NPI: 1336186410Individual
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
028137(GA)
Research & Publications (20)
Renin inhibition: the next step in suppression of the renin-angiotensin system?
PMID 17442216·Curr Hypertens Rep·2007
8-other
Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans.
PMID 16413241·Clin Pharmacol Ther·2006
2-rct
Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) study.
PMID 16732017·Diabetes Care·2006
4-observational
Renin inhibition with aliskiren: where are we now, and where are we going?
PMID 16508564·J Hypertens·2006
6-review
Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans.
PMID 15765151·J Clin Invest·2005
7-preclinical
Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
PMID 15173039·Circulation·2004
6-review
Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption.
PMID 15579516·J Am Soc Nephrol·2004
3-trial
[Blockade of the renin-angiotensin system by a combination of ACE inhibitors and AT1 receptor antagonists].
PMID 15496022·Rev Prat·2004
6-review
Integrating drug pharmacokinetics for phenotyping individual renin response to angiotensin II blockade in humans.
PMID 15023936·Hypertension·2004
3-trial
Dual renin-angiotensin system blockade restores blood pressure-renin dependency in individuals with low renin concentrations.
PMID 14508195·J Hypertens·2003
3-trial
Functional consequences of angiotensin-converting enzyme gene polymorphism on N-acetyl-Ser-Asp-Lys-Pro degradation and angiotensin II production.
PMID 12185449·J Mol Med (Berl)·2002
3-trial
Physiologic consequences of vasopeptidase inhibition in humans: effect of sodium intake.
PMID 12239234·J Am Soc Nephrol·2002
3-trial
Split renal function outcome after renal angioplasty in patients with unilateral renal artery stenosis.
PMID 11373347·J Am Soc Nephrol·2001
8-other
Angiotensin I-converting enzyme and metabolism of the haematological peptide N-acetyl-seryl-aspartyl-lysyl-proline.
PMID 11903317·Clin Exp Pharmacol Physiol·2001
7-preclinical
Influence of the M235T polymorphism of human angiotensinogen (AGT) on plasma AGT and renin concentrations after ethinylestradiol administration.
PMID 11095476·J Clin Endocrinol Metab·2000
8-other
In vitro and in vivo inhibition of the 2 active sites of ACE by omapatrilat, a vasopeptidase inhibitor.
PMID 10856268·Hypertension·2000
3-trial
Pilot study of combined blockade of the renin-angiotensin system in essential hypertensive patients.
PMID 10954007·J Hypertens·2000
3-trial
Managing cardiovascular and renal risk: the potential of direct renin inhibition.
PMID 19502253·J Renin Angiotensin Aldosterone Syst·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1000 MEDICAL CENTER BLVD
LAWRENCEVILLE, GA 30046 - Phone
- (770) 277-3056
Quick Facts
- NPI
- 1336186410
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile